Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Hematology Oncology Services of Arkansas

     
Little Rock , AR 72205
USA

 

Principal Investigator:
 Brad Baltz, MD
Contact:
 Priscilla Gray 501-320-3217 Priscilla.Gray@hosaoa.com Joanna Tucker 501 907 6444 Joanna.Tucker@hosaoa.com
Activation Status of this Site:
 Closed
Notes about this Site:
Hematology Oncology Services of Arkansas Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.